Loading clinical trials...
Loading clinical trials...
Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia in Adults
Conditions
Interventions
Bortezomib
Locations
1
Brazil
Instituto do Cancer do Estado de Sao Paulo
São Paulo, São Paulo, Brazil
Start Date
April 1, 2024
Primary Completion Date
August 1, 2028
Completion Date
August 1, 2029
Last Updated
May 16, 2025
NCT07371403
NCT05292664
NCT06316856
NCT05658640
NCT05745714
NCT05809284
Lead Sponsor
Instituto do Cancer do Estado de São Paulo
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions